Guidance for eCTD [Regulatives / Guidelines]

posted by shankar – India, 2008-03-10 11:16 (6686 d 01:46 ago) – Posting: # 1667
Views: 4,103

Dear Helmut & All,

Please guide us to prapare eCTD format for bioequivalence study for FDA submission.

Currently we refer "Guidence for industry Preparation of new drug submissions in the CTD format". Is it necessary to give all information mentioned in Module 1 to Module 5 for bioequivalence study from this guideline.

Please let us know where can we get exact information about eCTD (ANDA) submission for bioequivalence studies.


Shankaranarayanan J
Sitec Labs Pvt Ltd,
Mumbai, India.

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
317 visitors (0 registered, 317 guests [including 22 identified bots]).
Forum time: 14:02 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5